ai-oko is an innovative health technology company focused on leveraging artificial intelligence to improve ophthalmic diagnostics and patient outcomes. Their primary solutions aim to provide accessible and efficient screening for eye diseases, with a significant emphasis on diabetic retinopathy detection. By developing advanced AI algorithms, ai-oko strives to empower healthcare professionals and make early intervention more achievable, ultimately preserving vision for patients worldwide. The company is committed to making cutting-edge eye screening available in diverse healthcare settings, from specialist clinics to high street opticians.
Serves as the central hub for research and development of AI algorithms, strategic partnerships, business development, and overall company operations.
Likely situated within a modern tech innovation centre like The Bradfield Centre, offering state-of-the-art facilities, collaboration spaces, and a network of other tech companies and researchers.
A dynamic, innovative, and collaborative environment driven by a mission to solve critical healthcare challenges. The culture likely emphasizes research, continuous learning, and agility, typical of a focused tech startup.
Cambridge provides access to world-class academic institutions, a rich talent pool in AI and life sciences, and a supportive ecosystem for health-tech innovation and investment.
While headquartered in the UK, ai-oko develops AI solutions with global applicability in mind. Their technology is designed to be scalable and deployable in diverse healthcare systems worldwide to support ophthalmologists and optometrists in early disease detection. Their aim is to address the global challenge of preventable blindness, particularly focusing on conditions like diabetic retinopathy which affect populations internationally. Strategic partnerships and future market expansion will likely extend their direct operational presence.
The Bradfield Centre, 184 Cambridge Science Park, Milton Road (General Area as specific suite may vary)
Cambridge
Cambridgeshire
United Kingdom
Address: No other publicly listed office locations beyond Cambridge.
Focus remains on leveraging the Cambridge ecosystem for growth and innovation.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, ai-oko' leadership includes:
ai-oko has been backed by several prominent investors over the years, including:
ai-oko is a focused startup with a stable core leadership team. No major public announcements regarding executive hires or exits have been made in the last 12 months, reflecting continuity in its strategic direction since its recent funding.
Discover the tools ai-oko uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Common email formats for companies like ai-oko, especially tech startups, often use a combination of first name, last name, or initials. Based on typical startup conventions, a likely format is [first]@ai-oko.com.
[first]@ai-oko.com
Format
anna@ai-oko.com
Example
70%
Success rate
BusinessCloud • November 1, 2023
ai-oko, a Cambridge-based AI startup focused on eye health, secured £820,000 in pre-seed funding. The round was led by Crista Galli Ventures and Nina Capital, with participation from SyndicateRoom's Access, Calm Storm, and an Innovate UK grant. The funds will be used to further develop their AI technology for early detection of eye diseases like diabetic retinopathy....more
UKTN (UK Tech News) • October 31, 2023
AI-OKO announced it has raised £820,000 in a pre-seed funding round. The investment will help the company advance its AI-powered eye screening technology, aiming to make it accessible in high street opticians and other primary care settings for early disease detection....more
Crista Galli Ventures • October 31, 2023
Crista Galli Ventures announced its investment in AI-OKO's £820,000 pre-seed funding round. The company develops AI tools for ophthalmology to enable early, accessible, and equitable eye disease screening, starting with diabetic retinopathy....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including ai-oko, are just a search away.